Professor Alan Rickinson’s team are working to transform treatment for Epstein Barr Virus (EBV) associated cancers, and develop a vaccine to protect against EBV infection in the first instance. His team includes colleagues from the USA, Netherlands, UK, Australia, Germany, Switzerland, Japan and China.
Professor Roy Bicknell’s team are looking to develop a vaccination that would block the earliest onset of tumour growth by inhibiting a key step to halt the spread of cancerous cells. His team includes colleagues from the USA, UK, Netherlands, Sweden and Switzerland.
The teams will now receive seed-funding to draft their full research proposal, and the winning proposal from the nine entries will be announced in autumn 2016.
Prof Rickinson said “EBV is linked to 200,000 cases of cancer each year. The University of Birmingham has been a major centre of EBV research for over 25 years”.
Fellow team member Dr Graham Taylor said “We’re looking to attack EBV-associated cancer on two fronts. Discovering and testing new treatments to help existing patients and, at the same time, developing a vaccine that will prevent EBV infection occurring in the first place.”
Professor Bicknell explained, “Vaccinations have been one of the major success stories of the past 150 years, by combatting infectious diseases such as polio and smallpox. The ultimate challenge would be to create a vaccination that protects individuals against the development of cancer. Cancers need a blood supply to develop, and they do this through a process called angiogenesis – the creation of new blood vessels. Our team is looking to see how we might be able to prevent cancerous cells from being able to create new blood vessels.”
The Grand Challenge award aims to revolutionise how we diagnose, prevent and treat cancer by uniting teams of the best scientists around the world to come up with answers to crucial questions about how to save more lives from cancer.
Sir Harpal Kumar, Cancer Research UK’s chief executive, said, “The calibre of applications for our Grand Challenge is evidence of the remarkable global talent working in cancer research. It’s inspiring to see scientists of all disciplines and nations unite in the fight against the disease.”
Dr Rick Klausner, chair of the Grand Challenge advisory panel, said, “With so many exceptional teams proposing novel approaches, it was no easy task to pick our shortlist, but we’re delighted with the teams we’ve selected and look forward to hearing more about their plans to beat the toughest questions in cancer. At least one of these teams will be awarded the first ever Grand Challenge award later this year.”
For interview requests with the two teams, or for more information, please contact Luke Harrison, Media Relations Manager, University of Birmingham on +44 (0)121 414 5134.
For media enquiries about Cancer Research UK’s Grand Challenge award contact Emily Head in the Cancer Research UK press office on 020 3469 8300 or, out of hours, on 07050 264 059.
Notes to editor:
See website for more information: http://www.cancerresearchuk.org/funding-for-researchers/how-we-deliver-research/grand-challenge-award
About Cancer Research UK
- Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research.
- Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
- Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
- Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last forty years.
- Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK’s ambition is to accelerate progress so that 3 in 4 people will survive their cancer for at least 10 years within the next 20 years.
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.